Stay informed with the latest litigation news. Explore now

IP Verse

Novo Nordisk competitive analysis

Latest publications and patents of Novo Nordisk New

Explore the latest publications and patents granted to Novo Nordisk, showcasing their recent innovations and technological advancements.

Last updated on: Sep 6, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Novo Nordisk

EP4482490
Aug 20, 2025Methods For Treating Subjects With Abdominal Obesity Hypertriglyceridemia And/Or Impaired GlucosePending
EP4479402
Aug 6, 2025Pyrazolopyrimidines, Compositions Comprising Them And Uses ThereofPending
EP4076599
Aug 6, 2025Fixed Dose Injection DeviceGranted
EP4076598
Aug 6, 2025Fixed Dose Injection DeviceGranted
EP3689365
Aug 6, 2025Use Of Long-Acting Glp-1 PeptidesGranted And Under Opposition
EP4591885
Jul 30, 2025Anti-Il-6 Antibody FormulationPending
EP3790575
Jul 30, 2025Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic AcidGranted
EP4284933
Jul 9, 2025Compositions And Methods For Inhibiting Gene Expression In The Central Nervous SystemPending
EP4262850
Jul 9, 2025Compositions And Methods For Site-Directed MutagenesisPending
EP4076594
Jul 9, 2025Drug Delivery Device For Delivering A Predefined Fixed DoseGranted

Latest oppositions filed by Novo Nordisk

Explore patent oppositions filed by Novo Nordisk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3056568
Methods For Controlling Blood Pharmacokinetics Of AntibodiesCHUGAI SEIYAKU KABUSHIKI KAISHAJun 15, 2022
EP3653223
Device For The Oral Delivery Of Therapeutic CompoundsRANI THERAPEUTICSMay 25, 2022
EP1869065
A Method Of Weak Partitioning ChromatographyWYETHFeb 5, 2021
EP3461478
Swallowable Drug Delivery DeviceRANI THERAPEUTICSJan 21, 2021
EP2544668
Therapeutic Agent Preparations For Delivery Into A Lumen Of The Intestinal Tract Using A Swallowable Drug Delivery DeviceINCUBE LABSApr 16, 2020
EP2515992
Swallowable Drug Delivery Device And Methods Of Drug DeliveryINCUBE LABSJul 9, 2019
EP2708559
Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 19, 2018
EP2786657
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSNov 6, 2018

Latest patents of Novo Nordisk opposed by its competitors

Explore Novo Nordisk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3689365
Aug 6, 2025Use Of Long-Acting Glp-1 Peptides4
EP3300721
Jan 8, 2025Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices5
EP2729202
Nov 6, 2024Drug Delivery Injection Pen With Add-On Dose Capturing And Display Module1
EP3897582
Sep 11, 2024Process Of Spray Drying Of Glp-1 Peptide1
EP4054620
May 29, 2024Glp-1 Receptor Agonists In Dementia2
EP3474820
Feb 7, 2024Glp-1 Compositions And Uses Thereof8
EP3250191
Jan 17, 2024Tablets Comprising Glp-1 Agonist And Enteric Coating1
EP3488857
Oct 4, 2023Compositions Of Glp-1 Peptides And Preparation Thereof5
EP3542790
Sep 13, 2023Compositions Comprising A Delivery Agent And Preparation Thereof7
EP3746111
Jul 19, 2023Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant4

Latest PTAB cases involving Novo Nordisk New

Discover the latest PTAB cases involving Novo Nordisk, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 12, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Novo Nordisk

IPR2024-00631Mar 1, 2024APOTEXNOVO NORDISKTerminated-Settled
IPR2024-00107Nov 2, 2023SUN PHARMACEUTICAL INDUSTRIESNOVO NORDISKTerminated-Settled
IPR2024-00009Oct 20, 2023DR REDDYS LABORATORIESNOVO NORDISKTerminated-Settled
IPR2023-00724Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKTerminated-Settled
IPR2023-00723Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKInstitution Denied
IPR2023-00722Mar 16, 2023MYLAN PHARMACEUTICALSNOVO NORDISKInstitution Denied
IPR2022-00657Mar 3, 2022FRESENIUS KABI USANOVO NORDISKTerminated-Settled
IPR2020-01252Jul 22, 2020PFIZERNOVO NORDISKTerminated-Settled
IPR2020-00324Dec 19, 2019PFIZERNOVO NORDISKTerminated-Settled
IPR2017-00028Oct 7, 2016LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIESNOVO NORDISK HEALTHCAREFinal Written Decision

Top competitors of Novo Nordisk

Top competitors of Novo Nordisk based on patent oppositions.